Raffaella Delleva
Overview
Explore the profile of Raffaella Delleva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bachmeier B, Mirisola V, Romeo F, Generoso L, Esposito A, Delleva R, et al.
Cell Physiol Biochem
. 2010 Aug;
26(3):471-82.
PMID: 20798532
Background: Several secondary metabolites from herbal nutrient products act as weak estrogens (phytoestrogens), competing with endogenous estrogen for binding to the estrogen receptors and inhibiting steroid converting enzymes. However, it...
2.
Mazibrada J, De Andrea M, Ritta M, Borgogna C, Delleva R, Pfeffer U, et al.
Cancer Lett
. 2009 Jun;
287(1):33-43.
PMID: 19553003
The Interferon-inducible gene, IFI16 has been implicated in the control of cell growth, apoptosis, angiogenesis and immunomodulation. In a previous study we demonstrated that restoring levels of IFI16 in a...
3.
AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies
Delleva R, Ambrosini C, Vannini N, Piaggio G, Albini A, Ferrari N
Cancer
. 2007 Sep;
110(9):2007-11.
PMID: 17823911
Background: Leukemias are dependent on Akt/NF-kappaB activation and angiogenesis. Methods: The antiangiogenic Akt/NF-kappaB inhibitor xanthohumol (XN) has in vitro activity against acute and chronic myelogenous leukemia cell lines (AML, CML)...
4.
Albini A, Fassina G, Nicolo M, Delleva R, Vene R, Cammarota R, et al.
Clin Exp Metastasis
. 2007 Jul;
24(7):485-93.
PMID: 17653825
Ocular tumors such as retinoblastoma and uveal melanoma have devastating effects on vision. Patients with uveal melanoma also have low 5-year survival rates, thus new therapeutic modalities are necessary. As...
5.
Bachmeier B, Nerlich A, Iancu C, Cilli M, Schleicher E, Vene R, et al.
Cell Physiol Biochem
. 2007 Feb;
19(1-4):137-52.
PMID: 17310108
Dissemination of metastatic cells probably occurs long before diagnosis of the primary tumor. Metastasis during early phases of carcinogenesis in high risk patients is therefore a potential prevention target. The...
6.
Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, et al.
J Immunol
. 2007 Jan;
178(2):1122-35.
PMID: 17202376
IFNs are highly pleiotropic cytokines also endowed with marked antiangiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma...
7.
Secchiero P, Corallini F, Gonelli A, Delleva R, Vitale M, Capitani S, et al.
Circ Res
. 2006 Dec;
100(1):61-9.
PMID: 17138942
Nutlin-3, a nongenotoxic activator of the p53 pathway, dose-dependently (range 0.1 to 10 micromol/L) inhibited the formation of capillaries in an in vivo matrigel assay, as well as the formation...
8.
Delleva R, Ambrosini C, Minghelli S, Noonan D, Albini A, Ferrari N
Carcinogenesis
. 2006 Sep;
28(2):404-13.
PMID: 16952909
Several natural compounds, especially plant products and dietary constituents, are able to exhibit 'angiopreventive' (anti-angiogenic chemoprevention) activities both in vitro and in vivo. Deguelin is a rotenoid of the flavonoid...
9.
Albini A, Delleva R, Vene R, Ferrari N, Buhler D, Noonan D, et al.
FASEB J
. 2006 Jan;
20(3):527-9.
PMID: 16403733
Xanthohumol (XN), the principal flavonoid of the hop plant (Humulus lupulus L.) and a constituent of beer, has been suggested to have potential cancer chemopreventive activities. We have observed that...
10.
Pfeffer U, Ferrari N, Delleva R, Indraccolo S, Morini M, Noonan D, et al.
Mutat Res
. 2005 Aug;
591(1-2):198-211.
PMID: 16084531
The anti-oxidants N-acetyl-l-cysteine (NAC) and (-)-epigallocatechin-3-gallate (EGCG) inhibit tumor vascularization by reducing endothelial cell migration and invasion in a similar, non additive and non synergistic manner but do not alter...